US Bancorp tanked yesterday as Bank of America basically reported earnings derived primarily from one time gains. Today, USB has reported real results, and the stock is up 9+%. I'm up nearly 20% since I purchased it a month or so ago - although I was also down 20% at one point.
I've said before that US Bancorp is the real deal.
Novartis is a high quality, diversified pharma company. I believe it's nearly on par with Johnson and Johnson. It doesn't have a lot of upcoming patent expirations and also has a strong generics division. [more]
Enterprise GP Holdings (EPE) increased its cash distribution rate to $0.485 per unit per quarter, a 14% increase from this quarter in 2008. [more]
Wells Fargo set off a rally in bank stocks and the broader market when it announced an earning surprise. [more]
Biogen's stock is up about 5% at the time of writing and was up about 8% yesterday. There are rumors of a takeover by Sanofi Aventis, as Reuters reports. [more]
Legacy Reserves LP (LGCY) announced a buyout offer from a private equity firm, Apollo Management, of $14 a share. That's significantly less than I think the stock could be worth. However, Legacy is under pressure from volatile commodity prices. It's one of the more aggressive picks I made - I was essentially betting on continued high commodity prices. I intend to cut my losses. [more]